Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|January 1, 1993
Effect of ouabain and hypothalamic, hypophysary inhibitory factor on rat mesangial cell proliferationA Montero, A Rodriguez-Barbero, M Ricote, et al.
Nature|January 9, 1998
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activationM Ricote, A C Li, T M Willson, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 13, 2006
P38 MAPK protects against TNF-alpha-provoked apoptosis in LNCaP prostatic cancer cellsM Ricote, I García-Tuñón, B Fraile, et al.
The Journal of Pathology|December 22, 2005
The p38 transduction pathway in prostatic neoplasiaM Ricote, I García-Tuñón, F Bethencourt, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitorJ M Sancho, E Garcia-Martin, R Garcia-Robles, et al.
Molecular Reproduction and Development|May 2, 2002
Immunohistochemical detection of the retinoid acid receptors (RXR-alpha, -beta, -gamma) and Farnesoid X-activated receptor (FXR) in the marbled newt along the annual cycleJ M Alfaro, M Ricote, M V T Lobo, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1995
Effect of hypothalamic-hypophysary inhibitory factor on mesangial cell activationA Rodríguez-Barbero, C Martínez-Salgado, A M Rodríguez-López, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoproteinM Ricote, J Huang, L Fajas, et al.
Semergen|June 16, 2023
[Therapeutic adherence of patients with cardiovascular risk in primary care. REAAP project]J Espinosa García, L Aliaga Gutiérrez, F López Simarro, et al.
Molecular and Cellular Biology|April 1, 1997
Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressorsJ DiRenzo, M Söderstrom, R Kurokawa, et al.
Pageof 3